Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Halozyme Therapeutic (HTI)

Halozyme Therapeutics
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:HTI
DateTimeSourceHeadlineSymbolCompany
07/05/200714:00PR Newswire (US)Halozyme Therapeutics to Hold Business Update Conference Call on May 11AMEX:HTIHalozyme Therapeutics
02/05/200714:00PR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
02/05/200714:00PR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
30/04/200714:00PR Newswire (US)Halozyme Therapeutics Announces Nasdaq Global Market Listing ApprovalAMEX:HTIHalozyme Therapeutics
27/04/200715:00PR Newswire (US)Baxter Introduces HYLENEX for Use in Ophthalmic SurgeryAMEX:HTIHalozyme Therapeutics
24/04/200714:00PR Newswire (US)Halozyme Therapeutics Announces $32.1 Million Private FinancingAMEX:HTIHalozyme Therapeutics
13/03/200722:00PR Newswire (US)Halozyme Therapeutics Adopts SEC Rule 10b5-1 PolicyAMEX:HTIHalozyme Therapeutics
08/03/200713:00PR Newswire (US)Halozyme Therapeutics Reports Fourth Quarter and Year End 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
07/03/200713:00PR Newswire (US)Halozyme Therapeutics to Present at the Cowen & Company 27th Annual Health Care ConferenceAMEX:HTIHalozyme Therapeutics
06/03/200713:00PR Newswire (US)Halozyme Therapeutics to Hold 2006 Fourth Quarter and Year End Conference Call on March 8AMEX:HTIHalozyme Therapeutics
14/02/200721:31PR Newswire (US)Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine StudyAMEX:HTIHalozyme Therapeutics
14/02/200713:00PR Newswire (US)Halozyme and Baxter Expand Global HYLENEX CollaborationAMEX:HTIHalozyme Therapeutics
13/02/200713:00PR Newswire (US)Halozyme therapeutics to Present at the Roth Capital Partners 19th Annual OC ConferenceAMEX:HTIHalozyme Therapeutics
22/01/200713:00PR Newswire (US)Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large PrAMEX:HTIHalozyme Therapeutics
03/01/200713:00PR Newswire (US)Halozyme Therapeutics to Present at the JPMorgan 25th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
05/12/200622:48PR Newswire (US)Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug DeliveryAMEX:HTIHalozyme Therapeutics
27/11/200613:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
27/11/200613:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
20/11/200613:00PR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
20/11/200613:00PR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
09/11/200621:05PR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
09/11/200621:05PR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
08/11/200621:00PR Newswire (US)Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & OperationsAMEX:HTIHalozyme Therapeutics
01/11/200618:55PR Newswire (US)Halozyme Therapeutics to Present at the Rodman and Renshaw 8th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
26/10/200614:00PR Newswire (US)New Survey Reveals Most Patients Are Unaware That Slaughterhouse-Derived Animal Products Are Used in a Majority of IVF ProcedureAMEX:HTIHalozyme Therapeutics
12/10/200614:00PR Newswire (US)Halozyme Therapeutics to Present at the 2006 Bio InvestorForumAMEX:HTIHalozyme Therapeutics
10/10/200614:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Infuse-Morphine Clinical TrialAMEX:HTIHalozyme Therapeutics
19/09/200614:00PR Newswire (US)Halozyme Therapeutics to Present at the Noble Financial Small Cap ConferenceAMEX:HTIHalozyme Therapeutics
13/09/200614:00PR Newswire (US)Halozyme Therapeutics Completes Call of Second Tranche of Warrants From January 2004 FinancingAMEX:HTIHalozyme Therapeutics
29/08/200614:00PR Newswire (US)Halozyme Therapeutics to Present at the Roth 2006 New York ConferenceAMEX:HTIHalozyme Therapeutics
 Showing the most relevant articles for your search:AMEX:HTI